Study examines antibody response to COVID-19 vaccination in patients with kidney failure
Moderna COVID vaccine offers protection for at least 6 months, study finds
6 April 2021Offer exercise, therapy, acupuncture, or antidepressants for chronic primary pain, says NICE
7 April 2021Study examines antibody response to COVID-19 vaccination in patients with kidney failure
In a recent study, most patients with kidney failure who were undergoing hemodialysis developed a substantial antibody response following the vaccination with the Pfizer-BioNTech vaccine against COVID-19, but it was significantly lower than that of individuals without kidney disease. The findings will appear in an upcoming issue of CJASN.
